CGEM (NASDAQ) - Dividend History and Outstanding Shares
No Dividends discovered - So far (until May 2024) CGEM does not pay dividends. Outstanding Shares evolving.
No Dividends
As of May 2024, Cullinan Oncology LLC (CGEM) does not pay a dividend.
As of May 2024, Cullinan Oncology LLC (CGEM) does not pay a dividend.
Outstanding Shares
What is the Trend of CGEM`s Outstanding Shares?
The Outstanding Shares of Cullinan Oncology LLC are growing at a rate of 17.19% per year on average over the last 10 years. The Correlation Coefficent of the Outstanding Shares is 60.00%. Investors should be aware that the price of a stock often is negatively affected by an increasing number of shares.Did Cullinan Oncology LLC ever had a Stock Split?
Yes, last Stock Split was on 2009-08-31 with a factor of 2:1. This stock split increased the number of shares and lowered the price per share by a ratio of 2.| Year | Number of Shares (Mill.) | Growth |
|---|---|---|
| 2023 | 42.79 | -6.46% |
| 2022 | 45.75 | +4.83% |
| 2021 | 43.64 | +3.97% |
| 2020 | 41.98 | +116.81% |
| 2019 | 19.36 |
Dividend Yields, Growth & Consistency
| Overall Dividend Rating | - | ||
| Dividends Paid 12m | - | Yield 12m | - |
| Dividends Paid Average 5y | - | Yield Average 5y | - |
| Growth Rate 5y | - | Yield on Cost 5y | - |
| Payout Consistency | - | First Payout | - |
| Compare CGEM Dividends with its Industry Peers | |||
No Dividends Paid
-- CGEM`s 0.00% Dividend Yield is calculated by dividing the dividend payments of the last 12-Months (TTM) of 0.00 by the current stock price.
- 0.00% Yield on Cost is the effective dividend income you'd receive today if you purchased the stock five years ago (Rate of the last 12 Months 0.00 divided by price 5 years ago).
- The 0.0% Payout Consistency of CGEM Dividends gauges Stability (Values above 80%) or Fragility (Values under 60%).
- The Average Dividend Growth Rate of 0.00% per year in the last 5-Years showcases CGEM`s commitment to shareholders. Steady or increasing dividends over time can be a sign of a healthy financial outlook.
Ratings surpassing 5 are regarded as favorable, while those exceeding 7.5 are exceptionally strong. The calculations includes: Yield, Yield on Cost, Consistency of Payouts and Growth Rates over time.